LeBonheur Children's Medical Center
Memphis, Tennessee, 38103, United States
NCT Number: NCT00831038
Infants less than 2 years old who have been newly diagnosed with problems swallowing will have pulmonary function tests performed to try to detect the presence of chronic lung disease. Six months later after the infants have received appropriate therapy for their swallowing problems, pulmonary function tests will be performed again to see if there has been any change in their chronic lung disease.
Looking for future studies?
Notify Me1 month–24 month
All sexes
Interventional
Not applicable
Memphis, Tennessee, 38103, United States
Twenty-five infants between the ages of 1 month and 24 months who have just been diagnosed with dysphagia via a modified barium feeding study will be recruited into the study. The infants will be sedated with chloral hydrate and have pulmonary functions measured (pre- and post-bronchodilator spirometry and lung volume) using the infant pulmonary laboratory. Treatment for the infants' dysphagia/chronic aspiration will be treated as determined by the primary care physicians. Six months later the infants will again be sedated and have pulmonary functions measured. Results of the two sets of tests will be compared statistically.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tests will be performed on study patients within 1 week of study enrollment and again 6 months later.
Time frame: On admission to study and 6 months later
University of Tennessee
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06112730
Chronic Disease, Chronic Lung Disease
New Taipei City, Taiwan
View Trial DetailsNCT03373539
Bronchopulmonary Dysplasia, Chronic Lung Disease
Cleveland, Ohio, United States
View Trial DetailsNCT06174207
Asthma, Bronchial Diseases
Winterthur, Canton of Zurich, Switzerland
View Trial DetailsNCT04037436
Arthritis, Bone Diseases
Cambridge, Ontario, Canada
View Trial Details